Haypp Group AB (FRA:8QG0)
€ 13.48 +0.50 (+3.85%) Market Cap: 418.24 Mil Enterprise Value: 438.33 Mil PE Ratio: 592.80 PB Ratio: 6.59 GF Score: 82/100

Q1 2026 Haypp Group AB (publ) Earnings Call Transcript

May 07, 2026 / 07:00AM GMT
Release Date Price: €11.64 (+2.65%)

Key Points

Positve
  • Haypp Group AB (FRA:8QG0) reported a 24% revenue growth at constant currency, driven by an increase in active customers and share of wallet.
  • Nicotine pouch volumes grew by 40% year-on-year, now making up 69% of total volume, indicating strong market demand.
  • The growth segment, particularly in the US and UK, showed exceptional performance with volumes up more than 100% in each market.
  • Gross profit increased by 20% with a stable gross margin, reflecting effective cost management and strategic reinvestment.
  • The company is on track to meet its 2028 targets, expecting revenue growth of 18% to 25% CAGR from 2024 at constant currency.
Negative
  • EBIT margins have reduced due to increased investment in the US and UK, expected to continue for the remainder of the year.
  • Adjusted EBIT for the quarter was SEK27 million, with a margin of 2.5%, down from 5.2% last year, reflecting the investment phase.
  • The company faces jurisdictional complexities around the sale of nicotine, which could pose regulatory challenges.
  • There is a potential impact from state-level taxes on nicotine pouches in the US, which could affect pricing dynamics.
  • The discontinuation of the vape and heat-not-burn category in the UK has negatively impacted sales in that segment.
Gavin O Dowd;publ;Chief Executive Officer
Haypp Group AB

()-

Good morning, everyone. -- and welcome to High Group's Q1 results. Our CFO, Peter Daly, and I Gavin O'Dowd, will take you through today's presentation. Starting on slide 3, which is the agenda for today. I will take you through an overview of Haypp and the Q1 performance highlights and Peter will take us through the consumer, financial and segment performances before I progress on our key strategic priority markets, and an outlook.

I would like to take you to slide 5 to remind you of some of the key dynamics around our business. We are a retailer of risk-reduced products with a strong focus on nicotine purchase which, as of today, make up approximately 70% of our sales. We have multiple store fronts per market, and we offer -- and we operate in six markets in Europe and in the US,

Approximately 90% of our revenue comes from product sales with the sales of media & insights to brand owners accounting for just over 10%. While jurisdictional complexity around the sale of nicotine is often viewed

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot